Kliniska studier för KOL i Oklahoma
8 studier för KOL söker deltagare vid platser i Oklahoma.
Städer i Oklahoma
Officiell studietext (engelska)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Norman
- Research Site, Oklahoma City
- Research Site, Tulsa
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Layrek Clinical Research- Site Number : 8400066, Tulsa
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Epic Medical Research - Chickasha- Site Number : 8400097, Chickasha
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Oklahoma City
- Research Site, Tulsa
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Oklahoma City
- Research Site, Tulsa
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Oklahoma City
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06883305eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Edmond
RekryterarFas 3
Ålder 40 till 75 · Alla kön · Uppdaterad 28 juli 2026 · NCT07177339Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hightower Clinical, Oklahoma City
RekryterarObservationsstudie
Ålder 50 och äldre · Alla kön · Uppdaterad 5 aug. 2025 · NCT06122077Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.